Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hovdal

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cephalalgia : an International Journal of Headache|June 1, 1987
"Cervicogenic headache": clinical manifestationT A Fredriksen, H Hovdal, O Sjaastad
Cephalalgia : an International Journal of Headache|September 1, 1982
Ergotamine in plasma and CSF after i.m. and rectal administration to humansH Hovdal, G B Syversen, J Rosenthaler
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 25, 1998
[Neuralgic amyotrophy or an isolated lesion of the anterior interosseal nerve?]T Sand, H J Johnsen, H Hovdal, et al.
Acta Neurologica Scandinavica|June 15, 2011
Comparison of carbamazepine rash in multiple sclerosis and epilepsyM Shirzadi, S Alvestad, H Hovdal, et al.
Scandinavian Journal of Rehabilitation Medicine|January 1, 1982
The value of dorsal column stimulation in multiple sclerosisV Berg, S Bergmann, H Hovdal, et al.
Neuroepidemiology|July 21, 2012
Modelling and prediction of 25-hydroxyvitamin D levels in Norwegian relapsing-remitting multiple sclerosis patientsJ Saltytė Benth, K-M Myhr, K I Løken-Amsrud, et al.
Acta Neurologica Scandinavica|June 4, 2015
WT1 and interferon-β-vitamin D association in MS: a longitudinal studyT Holmøy, Q Y Esbensen, Ø Torkildsen, et al.
European Journal of Neurology|February 8, 2005
IL-10 promoter haplotype influence on interferon treatment response in multiple sclerosisS Wergeland, A Beiske, H Nyland, et al.
European Journal of Neurology|March 22, 2016
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patientsS Wergeland, K-M Myhr, K I Løken-Amsrud, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cephalalgia : an International Journal of Headache|June 1, 1987
"Cervicogenic headache": clinical manifestationT A Fredriksen, H Hovdal, O Sjaastad
Cephalalgia : an International Journal of Headache|September 1, 1982
Ergotamine in plasma and CSF after i.m. and rectal administration to humansH Hovdal, G B Syversen, J Rosenthaler
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 25, 1998
[Neuralgic amyotrophy or an isolated lesion of the anterior interosseal nerve?]T Sand, H J Johnsen, H Hovdal, et al.
Acta Neurologica Scandinavica|June 15, 2011
Comparison of carbamazepine rash in multiple sclerosis and epilepsyM Shirzadi, S Alvestad, H Hovdal, et al.
Scandinavian Journal of Rehabilitation Medicine|January 1, 1982
The value of dorsal column stimulation in multiple sclerosisV Berg, S Bergmann, H Hovdal, et al.
Neuroepidemiology|July 21, 2012
Modelling and prediction of 25-hydroxyvitamin D levels in Norwegian relapsing-remitting multiple sclerosis patientsJ Saltytė Benth, K-M Myhr, K I Løken-Amsrud, et al.
Acta Neurologica Scandinavica|June 4, 2015
WT1 and interferon-β-vitamin D association in MS: a longitudinal studyT Holmøy, Q Y Esbensen, Ø Torkildsen, et al.
European Journal of Neurology|February 8, 2005
IL-10 promoter haplotype influence on interferon treatment response in multiple sclerosisS Wergeland, A Beiske, H Nyland, et al.
European Journal of Neurology|March 22, 2016
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patientsS Wergeland, K-M Myhr, K I Løken-Amsrud, et al.
Pageof 1